Marie Bretagne - Pitié-Salpêtrière Hospital, Sorbonne Université

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 34 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Case Report: Immune Checkpoint-Inhibitor Related Myotoxicity Monitoring Using a Comprehensive Cardiothoracic MRI Approach: Insights from a Clinical Case

Samia Boussouar,Etienne Charpentier,Baptiste Abbar, Jesus Gonzalez,Thomas Similowski,Mathieu Kerneis,Yves Allenbach,Marie Bretagne,Joe Elie Salem,Alban Redheuil

Frontiers in cardiovascular medicine (2025): 1527048-1527048

引用0浏览0WOS引用

Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes

Etienne Charpentier,Samia Boussouar,Marie Bretagne,Khaoula Bouazizi,Nadjia Kachenoura, Lan Anh Nguyen,Nicoletta Pasi, Stephane Edhery,Yves Allenbach,Thomas Similowski,Mathieu Kerneis,Lauren Baldassarre,Joe-Elie Salem,Alban Redheuil

Journal of Cardiovascular Magnetic Resonance（2024）

引用0浏览0引用

Immune Checkpoint Inhibitors: the Spectrum of Neuromuscular Toxicity

Lotta Plomp, Hortense Chassepot, Dimitri Psimaras, Thierry Maisonobe, Eric Mensi,Sarah Leonard-Louis,Isabelle Plu,Antoine Rozes, Florence Tubach,Mehdi Touat,Celine Anquetil,Nadège Wesner,Nicolas Champtiaux,Aude Rigolet, Sophie Demeret, Nicolas Weiss,Marie-Alexandra Alyanakian, Marie-Agnès Dragon-Durey,Lucienne Chatenoud,Baptiste Abbar,Marie Bretagne,Adrien Procureur,Thomas Similowski, Capucine Morelot-Panzini, Martin Dres,Stéphane Ederhy, Olivier Benveniste,Joe-Elie Salem,Yves Allenbach

crossref（2024）

引用0浏览0引用

AbataCept Dose-Finding Phase II Trial for Immune Checkpoint Inhibitors Myocarditis (ACHLYS) Trial Design

Joe-Elie Salem,Stephane Ederhy,Lisa Belin,Noel Zahr, Florence Tubach,Adrien Procureur,Yves Allenbach, Michelle Rosenzwjag,Marie Bretagne

Archives of Cardiovascular Diseases (2024)

引用0浏览0WOS引用

Table S1 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

openalex（2023）

引用0浏览0引用

Supplementary Methods from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

openalex（2023）

引用0浏览0引用

Figure S2 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

openalex（2023）

引用0浏览0引用

Table S6 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

openalex（2023）

引用0浏览0引用

Figure S3 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

openalex（2023）

引用0浏览0引用

Figure S4 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn